540 Participants Needed

Palliative Care Models for Critical Condition

Recruiting at 1 trial location
VM
DS
Overseen ByDorothy Sheu, MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pennsylvania
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Accountable Justification, Default Order, Standardized Usual Care, Standard Care, Usual Medical Care for critical conditions?

Research shows that palliative care can improve the quality of care and reduce costs for patients with serious illnesses, as seen in Accountable Care Organizations (ACOs). This suggests that similar models, like the ones in the trial, could enhance patient-centered care and outcomes in critical conditions.12345

Is palliative care safe for humans?

The available research does not specifically address safety concerns for palliative care models, but these models are generally designed to improve patient-centered outcomes and are widely implemented in healthcare settings.24678

How is the treatment 'Accountable Justification, Default Order, Standardized Usual Care' unique for critical condition palliative care?

This treatment is unique because it integrates a structured approach to palliative care that aligns financial incentives with clinical benefits, focusing on reducing unnecessary hospital stays and promoting community-based care. It emphasizes a 'less is more' philosophy, which contrasts with traditional revenue-driven healthcare models, and aims to improve patient-centered care through innovative population management strategies.234910

What is the purpose of this trial?

Palliative care (PC) seeks to reduce suffering and improve quality of life for patients with serious illnesses and their families. National guidelines recommend that clinicians either provide palliative care themselves (generalist PC) or consult experts (specialist PC) as a standard part of serious illness care. This feasibility pilot study will be conducted with 6 hospitals at two large U.S. health systems and enroll 540 seriously ill hospitalized patients. Eligibility is determined by a mortality prediction score where enrolled patients have at least a 60% risk of dying within 1 year. Enrollment assessment occurs as close as possible to 36 hours post admission. In this cluster-randomized trial, the 6 hospitals will be randomized to 3 arms: (1) standardized usual care, (2) trained generalist PC, or (3) specialist PC. Generalists are trained using the Center to Advance Palliative Care (CAPC) online trainings. The pilot study will only measure process outcomes to assess the feasibility of a larger clinical trial (e.g., are the interventions working as intended). This pilot feasibility study is the precursor to a much larger pragmatic, hybrid effectiveness-implementation parallel-cluster RCT that will assess the comparative effectiveness of triggering generalist PC and specialist PC on several patient-centered outcome measures.

Research Team

KC

Katherine Courtright, MD, MS

Principal Investigator

University of Pennsylvania

SH

Scott D Halpern, MD PhD

Principal Investigator

University of Pennsylvania

Eligibility Criteria

This trial is for seriously ill hospitalized patients aged 18 or older, admitted to one of the study hospitals with a predicted mortality risk of at least 60% within the next year. It aims to improve their quality of life through palliative care.

Inclusion Criteria

I am admitted to a hospital participating in the study.
My doctor says I have a high risk (60% or more) of not surviving the next year.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

36 hours post admission

Treatment

Participants receive either standardized usual care, trained generalist palliative care, or specialist palliative care based on randomization

36 to 170 hours post admission

Follow-up

Participants are monitored for process outcomes and completion of patient-reported outcome surveys

3 months post-discharge

Treatment Details

Interventions

  • Accountable Justification
  • Default Order
  • Standardized Usual Care
Trial Overview The study compares three approaches: usual care without specific PC training, generalist PC where hospital staff are trained online in palliative care, and specialist PC provided by experts. The goal is to see which model works best for patient support.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: Trained Generalist Palliative CareExperimental Treatment2 Interventions
Generalist clinicians trained in PC domains receive an EHR-based alert to document whether or not they have addressed PC domains for moderately high-risk patients ('accountable justification intervention'). A specialist PC consult is ordered by default for the highest-risk patients unless clinicians cancel the order.
Group II: Specialist Palliative CareExperimental Treatment1 Intervention
A specialist PC consult is ordered by default for all patients with a ≥ 60% 1-year mortality risk ('default order intervention'), unless clinicians cancel the order.
Group III: Standardized Usual CareActive Control1 Intervention
Active control group, where moderately high-risk patients (e.g., with a 1-year mortality risk between 60% and 94%) will receive usual care. A specialist PC consult is ordered by default for the highest-risk patients (i.e., 1-year mortality risk ≥ 95%), unless clinicians cancel the order.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pennsylvania

Lead Sponsor

Trials
2,118
Recruited
45,270,000+

Duke Clinical Research Institute

Collaborator

Trials
69
Recruited
242,000+

Findings from Research

In Australia, over 85% of patients referred to specialized hospice/palliative care services have cancer, highlighting the importance of these services in cancer care, with data collected from 5,395 patients across 6,379 admissions.
The Palliative Care Outcomes Collaboration (PCOC) revealed significant variations in patient outcomes, such as stability after an unstable phase (12-fold differences) and improvements in symptom scores (seven-fold differences), indicating the need for ongoing data collection and benchmarking in palliative care.
Is it feasible and desirable to collect voluntarily quality and outcome data nationally in palliative oncology care?Currow, DC., Eagar, K., Aoun, S., et al.[2008]
Health care spending is expected to reach 19.6% of GDP by 2021, prompting the need for innovative care models to improve value, particularly through Accountable Care Organizations (ACOs) that assume financial risk for patient outcomes.
Palliative care can enhance the quality of care and reduce costs for high-risk patients within ACOs by implementing targeted interventions and population management strategies, thus playing a crucial role in optimizing patient-centered care.
The role of palliative care in population management and accountable care organizations.Smith, G., Bernacki, R., Block, SD.[2018]
Specialist palliative care (PC) can provide significant clinical benefits to patients while also aligning financial incentives for hospitals and payers, suggesting a need for a new business model that supports community-based PC.
Key developments supporting this model include penalties for excessive hospital stays, alternative payment models like accountable care organizations, and partnerships between payers and providers that enhance access to community-based PC services.
The Business Case for Palliative Care: Translating Research Into Program Development in the U.S.Cassel, JB., Kerr, KM., Kalman, NS., et al.[2018]

References

Is it feasible and desirable to collect voluntarily quality and outcome data nationally in palliative oncology care? [2008]
The role of palliative care in population management and accountable care organizations. [2018]
The Business Case for Palliative Care: Translating Research Into Program Development in the U.S. [2018]
Models for structuring a clinical initiative to enhance palliative care in the intensive care unit: a report from the IPAL-ICU Project (Improving Palliative Care in the ICU). [2022]
Does Receipt of Recommended Elements of Palliative Care Precede In-Hospital Death or Hospice Referral? [2021]
Rationale and Design of the Randomized Evaluation of Default Access to Palliative Services (REDAPS) Trial. [2022]
Inappropriate end-of-life cancer care in a generalist and specialist palliative care model: a nationwide retrospective population-based observational study. [2023]
Proposed quality measures for palliative care in the critically ill: a consensus from the Robert Wood Johnson Foundation Critical Care Workgroup. [2020]
A model to improve value: the interdisciplinary palliative care services agreement. [2009]
10.United Statespubmed.ncbi.nlm.nih.gov
Patient, Caregiver, and Taxpayer Knowledge of Palliative Care and Views on a Model of Community-Based Palliative Care. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security